FXAIX
Price
$190.53
Change
+$3.78 (+2.02%)
Updated
Apr 24 closing price
Net Assets
597.55B
HCPCX
Price
$47.88
Change
+$0.97 (+2.07%)
Updated
Apr 24 closing price
Net Assets
3.25B
Ad is loading...

FXAIX vs HCPCX

Header iconFXAIX vs HCPCX Comparison
Open Charts FXAIX vs HCPCXBanner chart's image
Fidelity 500 Index
Price$190.53
Change+$3.78 (+2.02%)
VolumeN/A
Net Assets597.55B
Hartford Capital Appreciation HLS IC
Price$47.88
Change+$0.97 (+2.07%)
VolumeN/A
Net Assets3.25B
FXAIX vs HCPCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FXAIX vs. HCPCX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FXAIX is a Buy and HCPCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
FXAIX has more cash in the bank: 598B vs. HCPCX (3.25B). FXAIX pays higher dividends than HCPCX: FXAIX (1.30) vs HCPCX (0.29). FXAIX was incepted earlier than HCPCX: FXAIX (14 years) vs HCPCX (11 years). HCPCX (1.17) is less costly to investors than FXAIX (0.01). HCPCX is a more actively managed with annual turnover of: 72.00 vs. FXAIX (2.00). FXAIX (0) and HCPCX (0) have matching initial minimum investment requirements. FXAIX annual gain was more profitable for investors over the last year : 7.42 vs. HCPCX (-1.13). FXAIX return over 5 years is better than : 104.55 vs. HCPCX (20.14).
FXAIXHCPCXFXAIX / HCPCX
Total Expense Ratio0.011.171%
Annual Report Gross Expense Ratio0.011.171%
Fund Existence14 years11 years-
Gain YTD-8.250-10.01382%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets598B3.25B18,377%
Annual Yield % from dividends1.300.29453%
Returns for 1 year7.42-1.13-654%
Returns for 3 years31.00-2.22-1,394%
Returns for 5 years104.5520.14519%
Returns for 10 years178.96-15.17-1,179%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TMCVX15.560.25
+1.63%
Thrivent Mid Cap Value S
MFRLX42.38N/A
N/A
MFS Research R1
MCGFX11.13N/A
N/A
AMG Montrusco Bolton Large Cap Growth N
RYVYX412.29N/A
N/A
Rydex NASDAQ-100® 2x Strategy H
NMGRX15.12N/A
N/A
Neuberger Berman Mid Cap Growth R3